A Case Based Update on Neurogenic Bladder - Jan 15, 2021 @1300EST

Using cases and the new CUA 2019 Guidelines on Neurogenic Lower Urinary Tract Dysfunction (NLUTD), I will enlighten participants on the current diagnosis, management and surveillance of their patients as well as answer their questions.

At the end of the session, participants will be able to:

  • Define and diagnose neurogenic lower urinary tract dysfunction (NLUTD) as per the 2019 CUA Guidelines
  • Describe the genitourinary sequalae of NLUTD over the lifetime of a patient
  • Use the patient risk stratification outlined in the new CUA guidelines to understand the surveillance strategy of NLUTD
  • Use cases to understand the impact of neurogenic bladder 

Speaker: Richard Baverstock, Clinical Associate Professor @University of Calgary

Host: Larry Robinson, MD, FABPMR, Professor and Division Director, Physical Medicine and Rehabilitation, Sunnybrook Research Institute

Primary Target audience: Physiatrists, Residents

Secondary: RNs, NPs, PAs

CanMEDS Roles: Medical Expert (the integrating role), Communicator, Health Advocate, Professional

This webinar was co-developed with Allergan and CAPMR and was planned to achieve scientific integrity, objectivity and balance.

CAPM&R Amputee SIG Virtual Learning Activity (Osseointegration & COVID-19) - Fri. Dec. 11, 2020

Speakers:

  • Osseointegration: Dre Nathalie Habra, Dre Jacqueline Hébert
  • COVID-19: Dre Amanda Mayo

 At the end of the session, participants will be able to:

  • Summarize the state of osseointegration in Canada at the present time
  • Generalize the impact of COVID on amputees' care

Moderator: Ariane Rajotte-Martel

Lisa Boivin - Thurs. Dec. 3, 2020

Speaker: Lisa Boivin

Join Dene Artist Lisa Boivin for a visually interactive presentation. Lisa uses the Indigenous methodology of collage to respond to the dearth of Indigenous content in rehabilitation science. While there is, literature revealing clinical barriers caused by colonialism, intergenerational trauma and a lack of cultural safety it is incomplete because it does not offer strength-based narratives that authentically reflect the identity of Indigenous people. Lisa will confront some of the colonial clinical problems that arise in rehabilitation and offer Indigenous teachings to resolve them.

 

 

Spasticity Management During Covid-19 Pandemic - Dec. 3, 2020

 This lecture will discuss the clinical recommendations focused on Spasticity Management During Covid-19 Pandemic

At the end of the session, participants will be able to manage spasticity patients during pandemic.

Panelists:
Rajiv Reebye, MD FRCPC, Clinical assistant professor in the department of Medicine at the University of British Columbia
Alessio Baricich MD PhD, Assistant Professor, Physical and Rehabilitation Medicine, Department of Health Sciences, Università del Piemonte Orientale

Moderator: Paul Winston, Associate Professor, University of British Columbia and the Island Medical Program

CanMEDS Roles: Medical Expert (the integrating role)

 

This webinar was co-developed with Allergan and CAPMR and was planned to achieve scientific integrity, objectivity and balance.

Integrative Approaches to Muscle Weakness in a Physiatry Setting - Nov. 17, 2020

The lecture will describe the physiological basis of muscle strength and the relevance this physiological parameter in clinical rehabilitation. A discussion of the methods to test and train strength will be included.

At the end of the session, participants will be able to:

1 : Describe and explain the physiological bases of muscle strength
2 : Identify the methods used in different setting to measure muscle strength
3 : Describe the importance of muscle strength in clinical outcomes
4 : Discuss the different strategies to increase strength with exercise

CanMEDS Roles: Medical Expert (the integrating role), Scholar

Target audience: Physiatrists, Medical Students, Residents

Speaker: Walter Frontera, MD, PhD, Professor, Departments of PM&R and Physiology at the University of Puerto Rico

Hosts: Paul Winston & Larry Robinson

New Development in Myotonic Dystrophy - Nov. 12, 2020

This webinar was co-developed with Sanofi Genzyme and CAPMR and was planned to achieve scientific integrity, objectivity and balance.

Myotonic dystrophy is the most common form of muscular dystrophy in adults. Multi-system involvement and phenotypic variability pose specific challenges to management and treatment. We will discuss new research developments with clinical relevance for Canadian healthcare professionals and patients,

At the end of the session, participants will be able to describe new developments in myotonic dystrophy.

Speaker: Dr. Hanns Lochmuller

Target audience: Physiatrists, Residents,

CanMEDS Roles: Medical Expert (the integrating role)

 

MEDICINE THROUGH MOVEMENT VIRTUAL WORKSHOP - Oct. 30, 2020

This webinar was co-developed with Sanofi Genzyme and CAPMR and was planned to achieve scientific integrity, objectivity and balance.

At the end of the session, participants will be able to:

1. Review the benefits of exercise and its role in disease prevention and management
2. Establish an approach to exercise counseling and the creation of an exercise prescription
3. Discuss the practical implementation of exercise promotion among individuals with and without disabilities.

Speakers:
Kim Coros, Bridgepoint Active Healthcare – Sinai Health System
Cathy J Campbell, Assistant Professor, U of T in the Department of Family and Community Medicine.

Hosts:
Paul Winston, MD FRCPC, Clinical associate professor, department of Medicine @University of British Columbia & Island Medical Program UBC
Larry Robinson, MD, FABPMR
Professor and Division Director, Physical Medicine and Rehabilitation, @Sunnybrook Research Institute

Target audience: Physiatrists, Residents, Medical Students, Physicians, PMR, Plastic Surgery, Orthopedics, pediatrics, Physio and OT, nurses, and Orthotists.

CanMEDS Roles: Medical Expert (the integrating role), Communicator, Health Advocate, Professional

 

ASSESSMENT AND TREATMENT OF CHRONIC MIGRAINE PATIENTS IN YOUR PRACTICE - OCT. 13, 2020

Diagnosis and treatment of chronic migraine patients. Review new Botox data. Introduce novel medications including the CGRP monoclonal antibodies, the gepants, ditans and Suvexx

Speaker: Dr. Corrie Graboski is a Physiatrist in Victoria, BC.

At the end of the session, participants will be able to:

  1. Describe a basic understanding of novel headache treatments
  2. Know an approach to the history and diagnosis of chronic migraine
  3. Recite the new literature on Botox and how it works with other migraine medications
  4. Describe the new CGRP blockers

Target audience: Physiatrists, Medical Students, Residents

CanMEDS Roles: Medical Expert (the integrating role), Communicator, Leader, Scholar, Professional.